News

CAGR growth through 2026 will be 6.4% per year

Deal for CHC Health adds depth, scale and expanded clinical expertise in health outcomes pursuits

Venture anticipated to more than double single-use bioreactor mammalian cell-culture capacity on site

Agency hopes Pfizer-BioNTech jab approval will convince some in public to get vaccinated

CDMO's expansion of Rensselaer, NY, facility will help grow its API division

Acquisition addresses the need for meeting healthcare sector’s patient support demand

Cardiff center will help produce lipids that are necessary for mRNA Covid vaccines

Developments include the creation of a new microbial facility, expansion of mammalian center

Deal allows for bicoastal expansion of pharmaceutical services

Company is also cited by SAP; meanwhile, HDA attendees get cautioned by FDA

Announcement only applies to mRNA doses at this point

End result is an enhanced method for developing vaccinia capping enzyme (VCE), parties say

CDMO’s future greater Boston facility to expand cGMP manufacturing capacity, accelerate commercial drug supply

Manufacturing center expected to integrate data analytics, machine learning into production process

Marks the fifth shot to receive emergency approval by Indian health authorities

Sets the scene for a messenger RNA production facility in Canada

Michigan site adds 110,000 square feet to its production footprint as company aims to meet additional demand

Acquisition boosts C&GT portfolio by 622,000 square feet, as CDMO eyes global expansion

CDMO's North Carolina development adds over 3,700 square feet worth of manufacturing space, equipment

Among focal points, New Jersey location will support clinical research, pharmacovigilance

Supply will start to become available in Q4 of this year, pending approval by EMA

CDMO says BFS capacity can now reach over 2 billion units yearly

WuXi STA will take reigns of the operations, as CDMO expands

Sector is expected to be driven by a rise in drug development and regulatory approvals for advanced therapies

Acquisition of US partner establishes Sanofi's plan to advance messenger RNA technology for vaccines, therapeutics

Guidance supports cross-industry collaboration for improved interoperability

Partnership to focus on gains for clinical development and commercialization through patient data curation and real-world data

June report reveals an 8% boost to air cargo market